NMPA Approval

Levetiracetam Concentrated Solution for Injection

Approval Number

国药准字H20213690

Company吉林省博大制药股份有限公司

Registration Date

September 1, 2021

Drug Information

Generic Name

左乙拉西坦注射用浓溶液

Dosage Form

注射剂

Strength

5ml:500mg

Drug Type

化学药品

Registration Date

September 1, 2021

Company Information

Applicant Company

Company Name吉林省博大制药股份有限公司

Company Address

吉林省辽源经济开发区财富大路58号

Manufacturing Company

Company Name吉林省博大制药股份有限公司

Company Address

吉林省辽源经济开发区财富大路58号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

左乙拉西坦注射用浓溶液 - NMPA 批准文号 | MedPath